ATRC (AtriCure) Valuation Rank


ATRC AtriCure Inc ATRC
78 GF Score
Price $30.12
GF Value $39.75
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is AtriCure Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

AtriCure Valuation Rank Related Terms

ATRC
78GF Score
AtriCure Inc ATRC
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtriCure (ATRC) Overvalued in 2026?

Based on GuruFocus' analysis, AtriCure stock appears to be undervalued. The current stock price of $30.12 is trading 24.2% below its estimated GF Value™ of $39.75. GuruFocus considers AtriCure to be Modestly Undervalued.

Key valuation signals for ATRC:

  • Valuation Rank:
  • GF Value™: $39.75 vs. price of $30.12 (24.2% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the ATRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtriCure Business Description

Address 7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
78GF Score

Get the complete analysis for ATRC

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.12
Price
$39.75
GF Value